Future trends in the prevalence of severe activity limitations among older adults in Europe: a cross-national population study using EU-SILC by Scherbov, Sergei & Weber, Daniela
ePubWU Institutional Repository
Serguei Scherbov and Daniela Weber
Future trends in the prevalence of severe activity limitations among older
adults in Europe: a cross-national population study using EU-SILC
Article (Published)
(Refereed)
Original Citation:
Scherbov, Serguei and Weber, Daniela (2017) Future trends in the prevalence of severe activity
limitations among older adults in Europe: a cross-national population study using EU-SILC. BMJ
Open, 7 (9). pp. 1-8. ISSN 2044-6055
This version is available at: http://epub.wu.ac.at/5841/
Available in ePubWU: November 2017
ePubWU, the institutional repository of the WU Vienna University of Economics and Business, is
provided by the University Library and the IT-Services. The aim is to enable open access to the
scholarly output of the WU.
This document is the publisher-created published version.
http://epub.wu.ac.at/
 1Scherbov S, Weber D. BMJ Open 2017;7:e017654. doi:10.1136/bmjopen-2017-017654
Open Access 
AbstrAct
Objective To project the proportion of population 65+ 
years with severe long-term activity limitations from 2017 
to 2047.
Design Large population study.
setting Population living in private households of the 
European Union (EU) and neighbouring countries.
Participants Participants from the EU Statistics on 
Income and Living Conditions aged 55 years and older and 
living in one of 26 EU and neighbouring countries, who 
answered the health section of the questionnaire.
Outcome measures Prevalence of severe long-term 
activity limitations of particular subpopulations (ie, 55+, 
65+, 75+ and 85+ years) by sex and country.
results We find a huge variation in the prevalence of 
self-reported severe long-term limitations across Europe 
for both sexes. However, in 2017, about 20% of the 
female population aged 65 years and above and about 
16% of their male counterparts are expected to report 
severe long-term activity limitations after accounting for 
differences in reporting. Accounting for cultural differences 
in reporting, we expect that European countries will have 
about 21% (decile 1: 19.5%; decile 9: 22.9%) of female 
and about 16.8% (decile 1: 15.4%; decile 9: 18.1%) of 
male 65+ years population with severe long-term activity 
limitations by 2047.
conclusions Overall, despite the expected increase of 
life expectancy in European countries, our results suggest 
almost constant shares of older adults with severe long-
term activity limitations within the next 30 years.
IntrODuctIOn
Worldwide populations are growing older. In 
upper middle-income and high-income coun-
tries, life expectancy is increasing and fertility 
rates are declining, leading to an increase of 
older populations. However, there is a lack 
of evidence whether these demographic 
changes are accompanied by an increase of 
frail or morbid people. The health status of 
older population is of raising public interest 
and a broadly discussed issue since many 
countries fear a rise in economic costs caused 
by ageing.
During the last decades, a large body of 
literature focused on health trends, which 
were often analysed with indicators using 
health-specific life expectancies.1–3 Research 
on trends in healthy life years (HLYs) and 
disability-free life expectancy showed an 
inconsistent pattern. For instance, in the early 
2000s, healthy life expectancy showed only 
little change for European men and women 
in contrast to their life expectancy,4 whereas 
it increased significantly between the early 
1980s and 2000s in Austria.5 Other studies 
showed that in the USA, higher educated 
population experienced some compression 
of morbidity, whereas their lower educated 
counterparts showed an expansion.6
There are inequalities in health expec-
tancies at older ages across the European 
Union (EU) and even within countries, and 
there are discrepancies between men and 
women.1 Even though women benefit from 
their mortality advantage over men when it 
comes to HLYs, the situation is sometimes the 
opposite. Women in general report higher 
prevalence of disabilities and frailty.7 Some 
research already explored this health-survival 
paradox.8 9
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Research
strengths and limitations of this study
 ► We used data on 26 European countries collected 
annually between 2008 and 2014.
 ► Applying the Sullivan method, we computed life 
expectancy without severe long-term activity 
limitations (healthy life years  (HLYs)) by sex and 
5-year age groups.
 ► We model the ratio of HLYs and life expectancy to 
predict prevalence of severe activity limitations 
among older adults.
 ► Cultural differences in self-reports are 
acknowledged, so we used a random intercept 
approach to consider those properly.
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Less research was focused on the impact of possible 
future trends in healthy and disability-free life expec-
tancy on the socioeconomic development of a country. 
For instance, are European health systems prepared for 
higher shares of older adults? Should we expect higher 
proportions of unhealthy older population?
The objective of this study is to provide an outlook on 
the future health status of older population measured by 
living with severe long-term limitations in daily activities. 
Based on the EU Statistics on Income and Living Condi-
tions (SILC) survey, we project the share of the 65+ years 
population living with severe long-term activity limitations 
for 26 European countries by 2047.
DAtA AnD methOD
Data
We used the EU-SILC data, which are conducted annually 
within EU member states and a few additional European 
states.10 This cross-sectional and longitudinal microdata 
provide information on income, poverty, social exclu-
sion and living conditions. Eurostat has coordinated the 
EU-SILC data since 2003, whereas national statistical insti-
tutes have collected the information, first in 6 countries 
and by 2014 in 31 countries.11 Although the sampling 
procedure varies across countries, the samples are consid-
ered nationally representative of individuals aged at least 
16 years living in private households.10 11 In our study, we 
focus on the global activity limitation indicator (GALI), 
which was designed for monitoring HLYs (ie, life expec-
tancy without long-term activity limitations) within the 
EU.12 This measure of general activity limitations was 
shown to be significantly associated with other health 
measures such as functional limitations, activities of daily 
living and instrumental activity of daily living.13 Since 
2008, GALI addresses the long-term activity limitations 
with the question ‘For at least the past 6 months, to what 
extent have you been limited because of a health problem 
in activities people usually do?’. There are some minor 
variations in the wording for the kind of activities across 
some countries ranging from usual, normal to daily activ-
ities (see ref 14). Therefore, we recoded the response 
categories ‘limited, but not severely’ and ‘not limited at 
all’ as having no severe difficulties and ‘severely limited’ as 
with severe limitations. Moreover, there might be variations 
in self-reports across cultures due to the uncertainty in 
defining ‘limited, but not severely’, so our recoding addi-
tionally addresses this potential bias.
We investigated the EU-SILC data provided by Eurostat 
restricting on the population aged at least 55 years from 
2008 to 2014 on an aggregated level by country, sex and 
5-year age groups. We also used sex-specific life tables 
provided by Eurostat for each country and each of our 
corresponding survey years.15 In addition, we used 
sex-specific life tables and age-specific and sex-specific 
population projections from 2015 to 2050 provided by 
the United Nations following the medium projection 
variant assumptions.16
methods
Prevalences of bad general health status are proxied by 
self-reported presence of long-term activity limitations 
(ie, the GALI). Sample weights are considered to account 
for non-response, so that the data are nationally repre-
sentative for the non-institutionalised population. Using 
the sex-specific and age group-specific prevalence rates 
and Eurostat life tables, we applied the Sullivan method 
to compute health-specific life expectancy, that is, 
remaining life expectancy without severe long-term 
activity limitations (also called healthy life years) for each 
country by 5-year age groups between 2008 to 2014.17 We 
determined sex-specific and age-specific HLY for each 
survey year and computed r , the ratio of HLY and life 
expectancy.4 18
Since our estimation of HLY is based on the self-re-
ported activity limitation status, country-specific cultural 
norms may play a crucial role in explaining big difference 
in the prevalence of severe long-term activity limitations. 
The generosity of social security systems may also play an 
important role in differences between countries. In this 
study, we tried to minimise this bias due to reporting style 
with regressing the ratio of HLY to life expectancy by sex 
for 26 upper middle-income and high-income countries 
across Europe using random intercept model.19 The 
significant group effect was identified with likelihood 
ratio tests for men and women. The between country 
variance explained more than 80% of the variance in 
r, the ratio of HLY to life expectancy, which supported 
our motivation to extinguish the potential cultural differ-
ences in self-reports.
Furthermore, we tested the importance of time, hence 
if there is a change in the proportion of remaining life 
years spent without severe long-term activity limitations 
(HLY/LE) over the years. While women showed no signif-
icant change across time, we identified a small significant 
increase of r  among men. Nevertheless, this increase was 
on average <0.025 units per year, which can be read as a 
prevalence increase of <0.5% points per year. Therefore, 
we decided to ignore this time effect for simplicity reasons 
and run the following model separately by sex
 
logit(ric) = β0 +
8∑
i=2
βiDic + u0c + εic
 (1)
with Dic a dummy variable for the 5-year age groups,  
indicating the first level aggregated by age group and year 
and c indicates the country group (second level).
Next, we used the sex-specific United Nations life 
tables for the years 2015–2050 to project HLY by age 
for those years using estimated r¯i, which represents the 
age group-specific ratio averaged across all countries. 
In order to perform comparative analysis, we used a 
sex-specific and age group-specific overall r¯i for all coun-
tries, rather than applying the country-specific estimated 
r¯ic because of the huge variation in country effects, which 
might be defined by cultural and norm differences in 
countries under consideration.20
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Figure 1 Self-reported severe activity limitations among at least 65 years old women across 26 European countries in 2014.
Figure 2 Self-reported severe activity limitations among at least 65 years old men across 26 European countries in 2014.
Having r¯i and the sex-specific projected life expectancy 
by age, we were able to calculate sex-specific HLY by age 
and to estimate the prevalence rate of people with severe 
long-term activity limitations, subsequently. Moreover, 
we projected the prevalence rate of people with severe 
long-term activity limitations and the proportion of older 
adults with severe long-term activity limitations from 2017 
to 2047 using age-specific and sex-specific United Nations 
population projections.
Since we applied the overall r¯i for all countries, the 
differences emerging in projected trends of prevalence 
of severe long-term activity limitations depend only on 
population age composition and projected life expectan-
cies. Moreover, while life expectancy is increasing and the 
ratio of HLY and life expectancy remains constant over 
time, HLY has to increase and it can decrease only with 
higher age. Hence, overall sex-specific and age group-spe-
cific good general health increases as well, which implies 
a decline in severe long-term activity limitations.
In addition, we performed some sensitivity analysis 
considering uncertainty in the estimates and provided a 
prediction interval around projected prevalences.
results
Comparing observed prevalence rates of severe long-term 
activity limitations of older adults (ie, 65+ years popula-
tion) across Europe, we identified huge disparities in 
the health of older adults across the investigated upper 
middle-income and high-income countries for both men 
and women (figures 1 and 2). For instance, in 2012 in 
Sweden, only 9.99% of the female 65+ years population 
reported severe long-term limitations, whereas about 
34.15% of their counterparts in Slovakia reported bad 
health (table 1). The range is a bit narrower for the 
male 65+ years population, the prevalence rates were 
between 6.44% and 27.6% in Malta and Slovakia, subse-
quently (table 1). In all countries, more women than men 
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Table 1 Prevalence rates of women and men aged at least 55, 65, 75 and 85 years with severe long-term activity limitations 
for 26 European countries in 2012
Country
Women Men
55+ 65+ 75+ 85+ 55+ 65+ 75+ 85+
Austria 19.1 23.3 32.6 46.4 17.3 19.9 28.5 40.6
Bulgaria 8.6 11.5 16.3 19.8 7.0 9.9 15.4 26.5
Czech Republic 12.6 15.9 25.4 33.6 10.1 11.6 19.4 27.9
Estonia 22.0 27.8 36.7 54.8 19.5 23.2 31.2 36.5
Finland 12.7 15.3 21.8 24.9 11.4 14.6 21.3 29.3
France 19.3 24.6 32.5 44.7 14.8 18.6 27.3 35.6
Germany 22.8 27.0 38.4 53.3 19.3 21.1 25.2 39.8
Greece 24.9 30.8 39.8 47.0 18.3 23.4 30.9 38.9
Hungary 17.3 22.9 32.4 42.5 14.8 18.6 25.0 38.9
Iceland 21.7 22.1 23.1 22.9 12.8 15.1 18.6 33.3
Ireland 9.3 11.6 15.0 27.6 11.2 14.4 18.5 27.4
Italy 20.8 27.2 37.6 49.3 15.0 19.8 27.5 34.4
Latvia 15.6 20.6 28.0 33.9 13.4 18.9 21.8 35.9
Lithuania 19.0 25.0 33.8 61.4 15.1 18.8 25.1 40.3
Luxembourg 13.0 17.0 21.0 20.0 11.1 13.2 18.7 27.2
Malta 8.5 12.2 23.0 36.9 5.2 6.4 12.4 15.1
Netherlands 9.6 11.6 16.6 17.6 9.4 10.4 15.5 16.4
Poland 15.8 21.4 30.5 43.9 14.8 19.1 26.0 39.9
Portugal 19.8 25.5 33.3 44.6 14.5 18.9 25.6 33.0
Romania 21.7 28.3 39.7 55.6 15.1 20.5 31.4 42.4
Slovakia 24.9 34.1 47.8 59.1 20.5 27.6 45.0 78.4
Slovenia 23.5 30.2 41.0 47.0 18.4 21.3 19.6 38.5
Spain 13.3 17.8 26.0 37.4 9.9 12.3 18.0 27.6
Sweden 10.2 10.0 12.7 15.3 7.2 8.0 14.0 22.5
Switzerland 10.2 11.3 14.7 18.9 8.1 8.7 10.7 15.3
UK 21.8 26.4 35.1 44.8 17.1 19.8 27.4 37.4
reported severe long-term activity limitations, although 
women tend to have higher life expectancy than men.
However, we observed a very pronounced difference 
in the prevalence of severe long-term activity limitations 
also among the countries where remaining life expec-
tancy at age 65 years often differs very little. Considering 
these variations between countries, our random inter-
cept regression showed a decline in the ratio of HLY to 
life expectancy by age, as expected. Moreover, the clear 
decline by age was of almost the same magnitude for 
both sexes (see online supplementary tables S1 and S2). 
Hence, men and women experienced the same speed of 
health deterioration.
We showed that the so-called burden of unhealthy 
population is very similar across European countries (see 
table 2), if we exclude cultural differences in reporting 
and consider only differences in age structure and life 
expectancy.
Controlling for cultural bias in self-reports, we noticed 
some changes over time in the ranking of countries with 
the highest and lowest level of older adults with severe 
activity limitations. For instance, Lithuania followed by 
Latvia had the highest shares of unhealthy 65 years and 
older adults in 2017. In 2047, Germany and the Nether-
lands can be expected to have the highest proportion 
of men above age 65 years with severe long-term activity 
limitations.
Furthermore, our results demonstrate almost no 
increase of the proportion of people with severe long-
term activity limitations for most European countries 
participating in EU-SILC. These results are valid both 
for men and women (see table 2). Within 30 years, the 
magnitude of change in the proportion of people 65+ 
years is less than 2.5% points among the female popula-
tion and even smaller among men (2% points).
In the online supplementary figures S1 and S2, we 
show the prediction intervals of the proportion of men 
and women at ages 65+ years based on uncertainty in 
parameter estimations related to the age effects. Very 
little uncertainty in age effects is translated into relatively 
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Table 2 Prevalence rates of at least 65 years old women and men with severe long-term activity limitations for 26 European 
countries in 2017, 2027, 2037 and 2047; in parentheses change since 2017.
Country
Women Men
2017 2027 2037 2047 2017 2027 2037 2047
Austria 20.68 20.21 (−0.47) 19.96 (−0.72) 21.40 (0.72) 16.17 15.93 (−0.24) 15.96 (−0.21) 17.25 (1.08)
Bulgaria 21.27 21.70 (0.43) 21.95 (0.68) 21.66 (0.39) 17.11 17.29 (0.18) 17.32 (0.21) 17.12 (0.01)
Czech 
Republic
20.02 20.89 (0.87) 21.49 (1.47) 20.63 (0.61) 15.83 16.46 (0.63) 16.7 (0.87) 16.16 (0.33)
Estonia 21.49 21.21 (−0.28) 21.73 (0.24) 21.86 (0.37) 16.85 16.48 (−0.37) 16.74 (−0.11) 16.80 (−0.05)
Finland 19.80 20.37 (0.57) 21.86 (2.06) 21.87 (2.07) 15.48 16.21 (0.73) 17.30 (1.82) 17.24 (1.76)
France 20.26 19.81 (−0.45) 20.71 (0.45) 21.52 (1.26) 15.94 16.08 (0.14) 16.76 (0.82) 17.20 (1.26)
Germany 21.22 20.61 (−0.61) 20.52 (−0.7) 22.28 (1.06) 16.56 16.20 (−0.36) 16.31 (−0.25) 17.79 (1.23)
Greece 21.01 20.72 (−0.29) 20.51 (−0.5) 21.06 (0.05) 17.11 16.74 (−0.37) 16.39 (−0.72) 16.58 (−0.53)
Hungary 21.05 21.34 (0.29) 21.87 (0.82) 21.01 (−0.04) 16.64 16.91 (0.27) 17.09 (0.45) 16.51 (−0.13)
Iceland 19.71 18.95 (−0.76) 20.06 (0.35) 21.01 (1.3) 15.43 15.15 (−0.28) 16.30 (0.87) 16.75 (1.32)
Ireland 19.25 19.37 (0.12) 19.78 (0.53) 19.86 (0.61) 15.43 15.57 (0.14) 15.82 (0.39) 15.97 (0.54)
Italy 20.62 20.36 (−0.26) 20.19 (−0.43) 21.51 (0.89) 16.27 16.20 (−0.07) 16.11 (−0.16) 17.07 (0.8)
Latvia 21.98 21.52 (−0.46) 21.74 (−0.24) 22.22 (0.24) 17.40 16.93 (−0.47) 17.05 (−0.35) 17.22 (−0.18)
Lithuania 22.21 21.24 (−0.97) 21.41 (−0.8) 22.61 (0.4) 18.27 16.92 (−1.35) 17.05 (−1.22) 17.57 (−0.7)
Luxembourg 20.51 19.26 (−1.25) 19.29 (−1.22) 20.24 (−0.27) 15.84 15.22 (−0.62) 15.45 (−0.39) 16.43 (0.59)
Malta 19.68 20.74 (1.06) 21.43 (1.75) 21.09 (1.41) 15.55 16.28 (0.73) 16.93 (1.38) 16.58 (1.03)
Netherlands 19.76 19.90 (0.14) 20.68 (0.92) 22.09 (2.33) 15.60 15.86 (0.26) 16.50 (0.9) 17.62 (2.02)
Poland 20.14 19.91 (−0.23) 21.77 (1.63) 21.03 (0.89) 15.98 15.85 (−0.13) 17.05 (1.07) 16.43 (0.45)
Portugal 20.73 20.45 (−0.28) 20.55 (−0.18) 21.12 (0.39) 16.53 16.33 (−0.2) 16.48 (−0.05) 16.88 (0.35)
Romania 21.24 21.15 (−0.09) 21.27 (0.03) 21.36 (0.12) 16.98 16.88 (−0.1) 16.88 (−0.1) 16.95 (−0.03)
Slovakia 20.29 20.21 (−0.08) 21.29 (1) 20.80 (0.51) 16.11 16.10 (−0.01) 16.86 (0.75) 16.38 (0.27)
Slovenia 20.76 20.14 (−0.62) 20.85 (0.09) 21.45 (0.69) 15.95 15.77 (−0.18) 16.56 (0.61) 16.91 (0.96)
Spain 20.69 19.86 (−0.83) 19.73 (−0.96) 20.64 (−0.05) 16.40 15.88 (−0.52) 15.81 (−0.59) 16.53 (0.13)
Sweden 20.05 20.71 (0.66) 20.95 (0.9) 21.18 (1.13) 15.68 16.49 (0.81) 16.67 (0.99) 16.94 (1.26)
Switzerland 20.12 19.74 (−0.38) 19.82 (−0.3) 21.04 (0.92) 15.71 15.69 (−0.02) 15.91 (0.2) 16.91 (1.2)
UK 20.37 20.25 (−0.12) 20.36 (−0.01) 21.25 (0.88) 16.07 16.13 (0.06) 16.20 (0.13) 16.87 (0.8)
narrow prediction intervals. The trends in proportion 
of people with severe long-term activity limitations are 
almost constant for most countries (eg, Estonia, Greece 
and Hungary). However, Germany and some other coun-
tries showed a slight increase and only a few countries 
such as Poland showed a slight decline in the proportion 
of people with severe long-term activity limitations (see 
online supplementary figures S1 and S2).
DIscussIOn
In this analysis of EU-SILC data, we investigated self-re-
ports in severe activity limitations of older adults in 26 
upper middle-income and high-income countries across 
Europe. Our results showed that HLY differ consider-
ably, which might be explained by self-reports. Countries 
with relatively similar levels of mortality, life expectancies 
and health systems are not expected to differ much in 
HLY apart from cultural differences in self-reports. For 
instance, Germany and the Netherlands are very similar 
in their remaining life expectancy at age 65 years (21 years 
for females and about 18 years for men), but they differ 
in terms of remaining life years without severe activity 
limitations; there is a gap of 3 years for women and about 
2 years for men (women: 15 years Germany, 18.4 years 
Netherlands; men: 13.8 years Germany, 18.4 years Neth-
erlands). Moreover, these potential cultural differences 
in self-reports are supported by our investigations in the 
ratio of HLY and life expectancy. Country differences 
explained 80% of the difference in the ratio. Another 
issue that may lead to the differences in self-reporting is 
the generosity of the welfare system. In more generous 
systems, higher reports of severe long-term activity limita-
tions might go together with the easier access to disability 
benefits. There might be also ‘true’ differences in self-re-
ported health attributed to different life styles in Euro-
pean countries or differences in genetics. However, one 
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would expect that morbidity and disability are also rela-
tively close, if the levels of mortality are very close.
We also showed that the ratio of remaining life expec-
tancy without severe long-term activity limitations to 
the total remaining life expectancy does not change 
with time for women and only little for men and that 
the so-called burden of unhealthy population is very 
similar across European countries once potential cultural 
differences in self-reports are excluded. Furthermore, 
the general concern that ageing is accompanied by an 
increase of disability may occur in the absolute level only, 
but more importantly, the proportion of adults aged 65+ 
years with severe long-term activity limitations will remain 
almost constant in the upcoming years, although total 
life expectancy is expected to increase. A recent study on 
disabilities (ie, difficulties with activities of daily living) 
suggests similar trends of no increase in the prevalence 
for England and Wales by 2025, but an increase of older 
people with care needs in absolute numbers.21 Interest-
ingly, research on trends between 1991 and 2011 using 
different English data showed that while more life years 
are spent healthy, less severe disabilities are increasing.22 
This increase in less severe disabilities might be in conse-
quence of variations in self-reports as also identified in 
our study or an increase in obesity.
However, there may be important policy implications 
derived from our results on trends in severe long-term 
activity limitations. Even though the trends in propor-
tion of people with limitations will remain constant, the 
absolute number of people with severe long-term activity 
limitations will definitely increase since the number 
of people at older ages is expected to increase in most 
European countries. It might require several measures 
to accommodate the needs of an increasing number 
of people with activity limitations such as expanding 
infrastructure for disabled people in the public as well 
as private area, training of medical specialists and care 
professionals.
Some limitations of this study should be noted. First 
of all, EU-SILC survey does not cover the institution-
alised population. Even though we have included sample 
weights to control for non-response, there was nothing 
we could do to include the institutionalised population 
within our projections. Another limitation is the appli-
cation of Sullivan method to compute HLY rather than 
using panel data, and calculating multistate life tables, 
but this is more a data limitation. Nevertheless, our 
study on future trends in the prevalence of severe long-
term activity limitations confirms a recent comment by 
Kenneth Rockwood. He stated that we should not expect 
to spend our whole life in good health,23 rather European 
countries might expect more older adults with severe 
long-term activity limitations but, in relative terms, the 
number stays constant.
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